Expression of heme oxygenase-1, hypoxia inducible factor-1α, and ubiquitin in peripheral inflammatory cells from patients with coronary heart disease

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 3, 2009, Pages 327-333

  Chen, Song Ming ^a   Li, Yu Guang ^a   Wang, Dong Ming ^a   Zhang, Guo Hong ^a   Tan, Chun Jiang ^b  

^a SHANTOU UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Coronary heart disease; Expression; Heme oxygenase 1; Hypoxia inducible factor 1 ; Ubiquitin

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; UBIQUITIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY DISEASE; FEMALE; GENE EXPRESSION PROFILING; HEME OXYGENASE-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UBIQUITIN;

ANGINA;

EID: 63849164205     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.073     Document Type: Article

References (31)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics. Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85-151.
2. Montuschi P, Ciabattoni G, Paredi P, Pantelidis P, duBois RM, Kharitonov SA. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998;158:1524-7.
3. Schnabel R, Blankenberg S. Oxidative stress in cardiovascular disease: successful translation from bench to bedside? Circulation 2007;116:1338-40.
4. Arzamastseva NE, Lankin VZ, Konovalova GG, Tikhaze AK, Ageev FT, Lapina YV, et al. Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus. Bull Exp Biol Med 2007;143:207-9.
5. Diaz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E,Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 1996;131:146-52.
6. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J1988;2:2557-68.
7. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000;279:L1029-37.
8. Chen SM, Li YG, Wang DM. Study on changes of heme oxygenase-1 expression in patients with coronary heart disease. Clin Cardiol 2005;28:197-201.
9. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-55.
10. Semenza GL. Hypoxia-inducible factor 1 and the molecularphysiology of oxygen homeostasis. J Lab Clin Med 1998;131:207-14.
11. Hicke L, Schubert HL, Hill CP. Ubiquitin-binding domains. Nat Rev Mol Cell Biol 2005;6:610-21.
12. Kikuchi J, Furukawa Y, Kubo N. Induction of ubiquitinconjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis. Arterioscler Thromb Vasc Biol 2000; 20:128-34.
13. Hon WC, Wilson MI, Harlos K. Structural basis for therecognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 2002;417:975-8.
14. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004;110:1296-302.
15. Inamoto S, Hayashi T, Tazawa N, Mori T, Yamashita C, Nakano D, et al. Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. Circ J 2006;70:787-92.
16. Urso ML, Clarkson PM, Hittel D, Hoffman EP, Thompson PD. Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins. Arterioscler Thromb Vasc Biol 2005;25:2560-6.
17. Nath KA, Balla G, Vercellotti G. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992;90:267-70.
18. Herrmann J, Edwards WD, Holmes DR, Shogren KL, Lerman LO, Ciechanover A, et al. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes. J Am Coll Cardiol 2002;40:1919-27.
19. Palombella VJ, Rando J, Goldberg A, Maniatis T. The ubiquitin-proteasome pathway is required for processing he NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994;78:773-85.
20. Wilson SH, Caplice NM, Simari RD, Holmes DR, Carlson PJ, Lerman A. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis 2000;148:23-30.
21. Kikuchi J, Furukawa Y, Kubo N. Induction of ubiquitinconjugatingenzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20: 128-34.
22. 22. Versari D, Herrmann J, Gössl M, Mannheim D, Sattler K, Meyer FB, et al. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:2132-9.
23. Dudek EJ, Shang F, Valverde P, Liu Q, Hobbs M, Taylor A. Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases. FASEB J 2005;19:1707-9.
24. Ikeda E. Cellular responses to tissue hypoxia and its involvement in disease progression. Pathol Int 2005; 55:603-10.
25. Giaccia A, Siim B, Johnson R. HIF-1 as target for drug development. Nat Rev Drug Disc 2003;2:803-11.
26. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92:5510-4.
27. Wenger RH, Gassmann M. Oxygen(es) and hypoxiainducible factor-1. Biol Chem 1997;378:609-16.
28. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000;279:L1029-37.
29. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-55.
30. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001;104:1519-25.
31. Sun L, Marti HH, Veltkamp R. Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia. Stroke 2008; 39:1000-6.